Benjamin Burnett analyst STIFEL

Currently out of the existing stock ratings of Benjamin Burnett, 83 are a BUY (62.88%), 48 are a HOLD (36.36%), 1 are a SELL (0.76%).

Benjamin Burnett

Work Performance Price Targets & Ratings Chart

Analyst Benjamin Burnett works at STIFEL with a stock forecast success ratio of 43.9% fulfilled within 68.74 days on average.

Benjamin Burnett’s has documented 259 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PGEN, Precigen at 15-May-2024.

Wall Street Analyst Benjamin Burnett

Analyst best performing recommendations are on EFTR (EFFECTOR THERAPEUTICS).
The best stock recommendation documented was for EFTR (EFFECTOR THERAPEUTICS) at 5/26/2023. The price target of $1.3 was fulfilled within 11 days with a profit of $0.64 (96.97%) receiving and performance score of 88.15.

Average potential price target upside

ALLO Allogene Therapeutics ATRA Atara Biotherapeutics BLUE Bluebird bio CRSP Crispr Therapeutics AG CTIC CTi Biopharma Corp DTIL Precision BioSciences FATE Fate Therapeutics GBT Global Blood Therapeutics IOVA Iovance Biotherapeutics MRTX Mirati Ther NKTR Nektar Therapeutics SGMO Sangamo Therapeutics PGEN Precigen IDYA Ideaya Biosciences RPTX Repare Therapeutics RVMD Revolution Medicines EFTR Effector Therapeutics GNCA Genocea Biosciences NLTX Neoleukin Therapeutics BEAM Beam Therapeutics  KNTE Kinnate Biopharma  ACLX Arcellx GRCL Gracell Biotechnologies .

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$6.23 (224.91%)

10

2 days ago

0/6 (0%)

$5.99 (199.00%)

Buy

17

$14.23 (513.72%)

3 days ago

2/10 (20%)

$14.02 (470.47%)

94

Hold

4.6

$1.83 (66.06%)

5

4 days ago

3/8 (37.5%)

$1.64 (55.41%)

11

Buy

8

$5.23 (188.81%)

9

2 months 21 days ago

0/3 (0%)

$2.86 (55.64%)

Buy

10

$7.23 (261.01%)

12

3 months 29 days ago

1/7 (14.29%)

$6.91 (223.62%)

28

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Benjamin Burnett is most bullish on?

Potential upside of $41.38 has been obtained for BEAM (BEAM THERAPEUTICS )

Which stock is Benjamin Burnett is most reserved on?

Potential downside of -$0 has been obtained for KNTE (KINNATE BIOPHARMA )

What Year was the first public recommendation made by Benjamin Burnett?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?